Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan
about
Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan
description
article publié dans la revue scientifique PLoS ONE
@fr
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in PLoS ONE
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Infliximab for pediatric patie ...... ed, multicenter trial in Japan
@en
Infliximab for pediatric patie ...... ed, multicenter trial in Japan
@nl
type
label
Infliximab for pediatric patie ...... ed, multicenter trial in Japan
@en
Infliximab for pediatric patie ...... ed, multicenter trial in Japan
@nl
prefLabel
Infliximab for pediatric patie ...... ed, multicenter trial in Japan
@en
Infliximab for pediatric patie ...... ed, multicenter trial in Japan
@nl
P2093
P2860
P1433
P1476
Infliximab for pediatric patie ...... ed, multicenter trial in Japan
@en
P2093
Atsuo Maemoto
Fukunori Kinjo
Hiroshi Yamada
Hitoshi Tajiri
Kazuoki Kondo
Kunihiko Ozaki
Mieko Nagano
Noriko Sato
Satoshi Motoya
Takayuki Matsumoto
P2860
P304
P356
10.1371/JOURNAL.PONE.0201956
P407
P577
2018-01-01T00:00:00Z